Skip to main content
. 2022 Nov 23;13:1062026. doi: 10.3389/fphar.2022.1062026

FIGURE 3.

FIGURE 3

DOSE analysis plots for the five ingredients, (A) HSYA, (B) SYR, (C) RU, (D) SCU and (E) p-CA with favorable PK properties. The top 20 diseases relative to the corresponding ingredient and potential targets are shown in the graphs.